Thursday’s market has seen notable movements across a spectrum of stocks, with some of the largest companies experiencing declines, while others in the large-cap space are on the rise. Mega-cap stocks like Oracle Corp (NYSE:ORCL) and Salesforce Com (NYSE:CRM) have seen a downturn, while large-cap players such as MicroStrategy Inc (NASDAQ:MSTR) are bucking the trend with impressive gains. Here’s a look at some of the most significant stock movers of the day, from mega-caps to small caps.
Mega-Cap Movers (Market Cap $200B+):
Oracle Corp (ORCL): -4.03% Salesforce Com (CRM): -3.84% Avago Technologies (NASDAQ:AVGO): -3.08% Servicenow Inc (NYSE:NOW): -2.68% Adobe Sys Inc (NASDAQ:ADBE): -2.21%Large-Cap Stock Movers (Market Cap $10B-$200B):
Dell Inc (NYSE:DELL): -12.25% Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36% MicroStrategy Inc (MSTR): +9.94% Autodesk Inc (NASDAQ:ADSK): -8.59% Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81% BeiGene (NASDAQ:BGNE): +7.31% Reinvent Technology Partners Y (AUR): +7.27% Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78% IBIT NASDAQ (IBIT): +6.44% FBTC NYSE (FBTC): +6.37%Mid-Cap Stock Movers (Market Cap $2B-$10B):
SVF Investment 3 (SYM): -35.87% Iris Energy (IREN): +29.71% Arrowhead Research Corp (NASDAQ:ARWR): +24.23% Urban outfitters (NASDAQ:URBN): +18.31% Hut 8 Mining PK (HUT): +16.5% HCM Acquisition (MRNO): +16.17% Good Works Acquisition (CIFR): +14.56% MSTU (MSTU): +13.93%Small-Cap Stock Movers (Market Cap $300M-$2B):
Advanced Photonix Inc (API): +33.97% ETHU (ETHU): +18.79% Golden Bull (BTBT): +18.45% Fate Therap (NASDAQ:FATE): +18.28% Kingsoft Cloud Holdings Ltd (KC): +17.42% Immunome Inc (NASDAQ:IMNM): +16.83% Wowo Ltd (MFH): -16.32% Semler Scientifc (NASDAQ:SMLR): +16.06% Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
